Published in Ophthalmology on September 01, 2003
The efficacy of automated "disease/no disease" grading for diabetic retinopathy in a systematic screening programme. Br J Ophthalmol (2007) 2.59
Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy. Invest Ophthalmol Vis Sci (2009) 2.17
Automated Quantification of Capillary Nonperfusion Using Optical Coherence Tomography Angiography in Diabetic Retinopathy. JAMA Ophthalmol (2016) 1.94
Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes. Invest Ophthalmol Vis Sci (2010) 1.73
Lack of association between thiazolidinediones and macular edema in type 2 diabetes: the ACCORD eye substudy. Arch Ophthalmol (2010) 1.68
Diabetic macular edema: what is focal and what is diffuse? Am J Ophthalmol (2008) 1.47
EyePACS: an adaptable telemedicine system for diabetic retinopathy screening. J Diabetes Sci Technol (2009) 1.46
Impact of white-coat hypertension on microvascular complications in type 2 diabetes. Diabetes Care (2008) 1.45
Noninvasive imaging of the foveal avascular zone with high-speed, phase-variance optical coherence tomography. Invest Ophthalmol Vis Sci (2012) 1.41
Photopic full-field electroretinography and optical coherence tomography in type 1 diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol (2015) 1.41
Proteomic analysis of human serum from diabetic retinopathy. Int J Ophthalmol (2011) 1.40
Prevalence of diabetic retinopathy in Tehran province: a population-based study. BMC Ophthalmol (2009) 1.34
Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study. Cardiovasc Diabetol (2013) 1.33
Early neurodegeneration in the retina of type 2 diabetic patients. Invest Ophthalmol Vis Sci (2012) 1.32
HbA1c variability as an independent correlate of nephropathy, but not retinopathy, in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study. Diabetes Care (2013) 1.31
The role of genetics in susceptibility to diabetic retinopathy. Int Ophthalmol Clin (2009) 1.30
Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in type 2 diabetic subjects without retinopathy. Diabetes Care (2011) 1.25
Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: meta-analysis of observational studies. Diabetes Care (2011) 1.23
Ethnic variations in the prevalence of diabetic retinopathy in people with diabetes attending screening in the United Kingdom (DRIVE UK). PLoS One (2012) 1.20
Optimal wavelet transform for the detection of microaneurysms in retina photographs. IEEE Trans Med Imaging (2008) 1.20
Changes of oscillatory potentials and photopic negative response in patients with early diabetic retinopathy. Jpn J Ophthalmol (2006) 1.19
Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness. Mol Vis (2009) 1.19
Diabetic retinopathy: an update. Indian J Ophthalmol (2008) 1.18
Risk factors associated with diabetic retinopathy in patients with diabetes mellitus type 2. BMC Res Notes (2010) 1.18
Prevalence of Metabolic Syndrome and its influence on microvascular complications in the Indian population with Type 2 Diabetes Mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 14). Diabetol Metab Syndr (2010) 1.16
Delivery of SAR 1118 to the retina via ophthalmic drops and its effectiveness in a rat streptozotocin (STZ) model of diabetic retinopathy (DR). Invest Ophthalmol Vis Sci (2010) 1.15
Genome-wide association study in a Chinese population with diabetic retinopathy. Hum Mol Genet (2013) 1.13
Peripheral sensory neuropathy associates with micro- or macroangiopathy: results from a population-based study of type 2 diabetic patients in Sweden. Diabetes Care (2008) 1.10
Diabetic retinopathy, visual impairment and ocular status among patients with diabetes mellitus in Yemen: a hospital-based study. Indian J Ophthalmol (2009) 1.10
Analysis of a comprehensive diabetic retinopathy screening model for rural and urban diabetics in developing countries. Br J Ophthalmol (2007) 1.08
Classification of human retinal microaneurysms using adaptive optics scanning light ophthalmoscope fluorescein angiography. Invest Ophthalmol Vis Sci (2014) 1.07
Classification of diabetic retinopathy and diabetic macular edema. World J Diabetes (2013) 1.06
Rate and determinants of association between advanced retinopathy and chronic kidney disease in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study. Diabetes Care (2012) 1.06
Assessment of diabetic retinopathy using nonmydriatic ultra-widefield scanning laser ophthalmoscopy (Optomap) compared with ETDRS 7-field stereo photography. Diabetes Care (2012) 1.04
Comparing the effectiveness of telemedicine and traditional surveillance in providing diabetic retinopathy screening examinations: a randomized controlled trial. Telemed J E Health (2013) 1.04
Arterial stiffness is associated with incident albuminuria and decreased glomerular filtration rate in type 2 diabetic patients. Diabetes Care (2011) 1.04
Aqueous concentrations of VEGF and soluble VEGF receptor-1 in diabetic retinopathy patients. J Res Med Sci (2012) 1.03
Association of visual function and ganglion cell layer thickness in patients with diabetes mellitus type 1 and no or minimal diabetic retinopathy. Vision Res (2010) 1.03
Neurodegeneration in the pathogenesis of diabetic retinopathy: molecular mechanisms and therapeutic implications. Curr Med Chem (2013) 1.03
Diabetic retinopathy and health-related quality of life. Graefes Arch Clin Exp Ophthalmol (2008) 1.03
Predicting macro- and microvascular complications in type 2 diabetes: the Japan Diabetes Complications Study/the Japanese Elderly Diabetes Intervention Trial risk engine. Diabetes Care (2013) 1.02
Spectral domain optical coherence tomography characteristics in diabetic retinopathy. Oman J Ophthalmol (2014) 1.00
Evaluation for fasting and 2-hour glucose and HbA1c for diagnosing diabetes based on prevalence of retinopathy in a Chinese population. PLoS One (2012) 1.00
High levels of serum prolactin protect against diabetic retinopathy by increasing ocular vasoinhibins. Diabetes (2010) 1.00
CPVL/CHN2 genetic variant is associated with diabetic retinopathy in Chinese type 2 diabetic patients. Diabetes (2011) 1.00
Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy. Clin Ophthalmol (2012) 0.96
Type 2 diabetes mellitus and microvascular complications 1 year after Roux-en-Y gastric bypass: a case-control study. Diabetologia (2015) 0.96
Retinopathy and risk factors in diabetic patients from Al-Madinah Al-Munawarah in the Kingdom of Saudi Arabia. Clin Ophthalmol (2012) 0.95
A proposed new classification for diabetic retinopathy: the concept of primary and secondary vitreopathy. Indian J Ophthalmol (2007) 0.95
Thresholds of various glycemic measures for diagnosing diabetes based on prevalence of retinopathy in community-dwelling Japanese subjects: the Hisayama Study. Cardiovasc Diabetol (2014) 0.95
The photopic negative response of flash ERG in nonproliferative diabetic retinopathy. Doc Ophthalmol (2008) 0.95
The economic burden of diabetic retinopathy in Germany in 2002. Graefes Arch Clin Exp Ophthalmol (2007) 0.94
Content based image retrieval based on wavelet transform coefficients distribution. Conf Proc IEEE Eng Med Biol Soc (2007) 0.93
Relationship between pigment epithelium-derived factor (PEDF) and renal function in patients with diabetic retinopathy. Mol Vis (2008) 0.93
The North Jutland County Diabetic Retinopathy Study: population characteristics. Br J Ophthalmol (2006) 0.93
Clinical Course and Risk Factors of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus in Korea. Diabetes Metab J (2016) 0.92
Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study. Cardiovasc Diabetol (2014) 0.92
Prospective comparison of two methods of screening for diabetic retinopathy by nonmydriatic fundus camera. Clin Ophthalmol (2010) 0.92
Risk factors associated with retinal neovascularization of diabetic retinopathy in type 2 diabetes mellitus. Int J Ophthalmol (2011) 0.92
Prevalence and associated factors of diabetic retinopathy in rural Korea: the Chungju metabolic disease cohort study. J Korean Med Sci (2011) 0.92
Multimedia medical case retrieval using decision trees. Conf Proc IEEE Eng Med Biol Soc (2007) 0.91
A prospective cross-sectional study on quality of life and treatment satisfaction in type 2 diabetic patients with retinopathy without other major late diabetic complications. Health Qual Life Outcomes (2014) 0.91
A morphological study of the foveal avascular zone in patients with diabetes mellitus using optical coherence tomography angiography. Graefes Arch Clin Exp Ophthalmol (2015) 0.90
An association between subclinical hypothyroidism and sight-threatening diabetic retinopathy in type 2 diabetic patients. Diabetes Care (2010) 0.90
Validation of tablet-based evaluation of color fundus images. Retina (2012) 0.90
The accuracy of digital-video retinal imaging to screen for diabetic retinopathy: an analysis of two digital-video retinal imaging systems using standard stereoscopic seven-field photography and dilated clinical examination as reference standards. Trans Am Ophthalmol Soc (2004) 0.90
Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A-dependent eNOS inactivation. J Clin Invest (2008) 0.89
Infant and toddler type 1 diabetes: complications after 20 years' duration. Diabetes Care (2012) 0.89
Implementation and first-year screening results of an ocular telehealth system for diabetic retinopathy in China. BMC Health Serv Res (2011) 0.89
A novel device for accurate and efficient testing for vision-threatening diabetic retinopathy. J Diabetes Complications (2015) 0.89
Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus. Proc Natl Acad Sci U S A (2016) 0.88
Factors associated with diabetic retinopathy in chinese patients with type 2 diabetes mellitus. Int J Endocrinol (2012) 0.88
The Role of the Reactive Oxygen Species and Oxidative Stress in the Pathomechanism of the Age-Related Ocular Diseases and Other Pathologies of the Anterior and Posterior Eye Segments in Adults. Oxid Med Cell Longev (2016) 0.88
Prevalence of diabetic retinopathy in individuals with type 2 diabetes who had recorded diabetic retinopathy from retinal photographs in Catalonia (Spain). Br J Ophthalmol (2015) 0.87
Predictors for diabetic retinopathy in normoalbuminuric people with type 2 diabetes mellitus. Diabetol Metab Syndr (2012) 0.87
HLA genes, islet autoantibodies and residual C-peptide at the clinical onset of type 1 diabetes mellitus and the risk of retinopathy 15 years later. PLoS One (2011) 0.87
Prevalence of low testosterone levels in men with type 2 diabetes mellitus: a cross-sectional study. J Family Community Med (2013) 0.87
Prevalence and risk factors for diabetic retinopathy in a high-risk Chinese population. BMC Public Health (2013) 0.86
Angiotensin blockade to reduce microvascular damage in diabetes mellitus. Dtsch Arztebl Int (2009) 0.86
Type 2 diabetes-associated carotid plaque burden is increased in patients with retinopathy compared to those without retinopathy. Cardiovasc Diabetol (2015) 0.86
Expression of CD18 on the neutrophils of patients with diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol (2006) 0.85
TOX and CDKN2A/B Gene Polymorphisms Are Associated with Type 2 Diabetes in Han Chinese. Sci Rep (2015) 0.85
Analysis of foveal avascular zone for grading of diabetic retinopathy severity based on curvelet transform. Graefes Arch Clin Exp Ophthalmol (2012) 0.85
The association of serum vascular endothelial growth factor and ferritin in diabetic microvascular disease. Diabetes Technol Ther (2013) 0.85
Cross Talk between Lipid Metabolism and Inflammatory Markers in Patients with Diabetic Retinopathy. J Diabetes Res (2015) 0.84
Comparison of standardized clinical classification with fundus photograph grading for the assessment of diabetic retinopathy and diabetic macular edema severity. Retina (2013) 0.84
A simplified diabetic retinopathy scale. Ophthalmology (2003) 0.84
Effects of bevacizumab on the neovascular membrane of proliferative diabetic retinopathy: reduction of endothelial cells and expressions of VEGF and HIF-1α. Mol Vis (2012) 0.83
Animal models of diabetic retinopathy: doors to investigate pathogenesis and potential therapeutics. J Biomed Sci (2013) 0.83
Risk factors for diabetic retinopathy: a case-control study. Int J Retina Vitreous (2016) 0.83
Economic evaluation of screening for diabetic retinopathy among Chinese type 2 diabetics: a community-based study in Kinmen, Taiwan. J Epidemiol (2008) 0.83
Frequency, severity and risk indicators of retinopathy in patients with diabetes screened by fundus photographs: a study from primary health care. Pak J Med Sci (2014) 0.83
Efficacy and safety of multiple intravitreal triamcinolone injections for refractory diabetic macular oedema. Br J Ophthalmol (2007) 0.83
Influence of retinopathy on the achromatic and chromatic vision of patients with type 2 diabetes. BMC Ophthalmol (2014) 0.83
Four-year incidence of diabetic retinopathy in a Spanish cohort: the MADIABETES study. PLoS One (2013) 0.83
Multiplex bead array assay of plasma cytokines in type 2 diabetes mellitus with diabetic retinopathy. Mol Vis (2014) 0.83
The 5-year onset and regression of diabetic retinopathy in Chinese type 2 diabetes patients. PLoS One (2014) 0.83
Automated diagnosis of diabetic retinopathy and glaucoma using fundus and OCT images. Lipids Health Dis (2012) 0.83
Diabetic retinopathy is associated with oxidative stress and mitigation of gene expression of antioxidant enzymes. Int J Gen Med (2013) 0.82
Complement factor H polymorphism in age-related macular degeneration. Science (2005) 31.10
Global data on blindness. Bull World Health Organ (1995) 12.05
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology (2012) 11.91
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology (2010) 10.28
A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol. Am J Ophthalmol (2003) 9.99
Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med (2012) 8.83
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med (2015) 7.08
The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol (2005) 4.46
Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology (2011) 4.15
[Epidemiological surveillance of trachoma: evaluation and perspective]. Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique (1992) 3.75
Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease. Am J Ophthalmol (2006) 3.66
2002 global update of available data on visual impairment: a compilation of population-based prevalence studies. Ophthalmic Epidemiol (2004) 3.41
Age-related macular degeneration. Lancet (2008) 3.34
Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology (2005) 3.28
Available data on blindness (update 1994) Ophthalmic Epidemiol (1995) 3.28
Increased prevalence of myopia in the United States between 1971-1972 and 1999-2004. Arch Ophthalmol (2009) 3.21
Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. Arch Ophthalmol (2003) 3.17
Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina (2006) 3.09
Prevalence of refractive error in the United States, 1999-2004. Arch Ophthalmol (2008) 3.06
The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22. Arch Ophthalmol (2007) 3.02
Panretinal photocoagulation for proliferative diabetic retinopathy. N Engl J Med (2011) 2.98
Diabetic retinopathy. Diabetes Care (2004) 2.97
Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: a clinicopathologic correlation. Am J Ophthalmol (2002) 2.95
The economic burden of major adult visual disorders in the United States. Arch Ophthalmol (2006) 2.92
A critical appraisal and comparison of the quality and recommendations of glaucoma clinical practice guidelines. Ophthalmology (2011) 2.82
Visual acuity as an outcome measure in clinical trials of retinal diseases. Ophthalmology (2007) 2.69
Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results. Ophthalmology (2012) 2.68
The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States. Ophthalmology (2009) 2.57
VISION 2020-the right to sight: from strategies to action. Am J Ophthalmol (1999) 2.49
Early rapid rise in intraocular pressure after intravitreal triamcinolone acetonide injection. Am J Ophthalmol (2004) 2.46
Long-term outcome of patients with a negative work-up for asymptomatic microhematuria. Urology (2009) 2.18
Epidemiologic aspects of global blindness prevention. Curr Opin Ophthalmol (1992) 2.14
The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. Arch Ophthalmol (2007) 2.12
Comparison of the efficacy of povidone-iodine 1.0%, 5.0%, and 10.0% irrigation combined with topical levofloxacin 0.3% as preoperative prophylaxis in cataract surgery. J Cataract Refract Surg (2013) 2.12
Ocular complications after anti-vascular endothelial growth factor therapy in Medicare patients with age-related macular degeneration. Am J Ophthalmol (2011) 2.07
High failure rate associated with 180 degrees selective laser trabeculoplasty. J Glaucoma (2005) 2.03
Outcome of accidental hypothermia with or without circulatory arrest: experience from the Danish Præstø Fjord boating accident. Resuscitation (2012) 1.94
The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23. Arch Ophthalmol (2008) 1.93
Serum inflammatory markers in diabetic retinopathy. Invest Ophthalmol Vis Sci (2005) 1.92
Epidemiology of blindness in Nepal. Bull World Health Organ (1985) 1.91
Microplasmin intravitreal administration in patients with vitreomacular traction scheduled for vitrectomy: the MIVI I trial. Ophthalmology (2009) 1.90
Longitudinal rates of postoperative adverse outcomes after glaucoma surgery among medicare beneficiaries 1994 to 2005. Ophthalmology (2008) 1.88
Potential adult Medicaid beneficiaries under the Patient Protection and Affordable Care Act compared with current adult Medicaid beneficiaries. Ann Fam Med (2013) 1.87
Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial. Lancet (2009) 1.83
ACAT2 is localized to hepatocytes and is the major cholesterol-esterifying enzyme in human liver. Circulation (2004) 1.76
Risk assessment model for development of advanced age-related macular degeneration. Arch Ophthalmol (2011) 1.75
The effect of indocyanine-green on functional outcome of macular pucker surgery. Am J Ophthalmol (2003) 1.74
Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report 25. Ophthalmology (2008) 1.69
Ultrastructure of the vitreomacular interface in full-thickness idiopathic macular holes: a consecutive analysis of 100 cases. Am J Ophthalmol (2006) 1.66
The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1). Ophthalmology (2012) 1.66
Hypothyroidism and the development of open-angle glaucoma in a male population. Ophthalmology (2004) 1.63
Blindness and visual impairment: a public health issue for the future as well as today. Arch Ophthalmol (2004) 1.63
Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology (2008) 1.60
Retinal precursors and the development of geographic atrophy in age-related macular degeneration. Ophthalmology (2007) 1.59
Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium. Invest Ophthalmol Vis Sci (2008) 1.58
Vitrectomy does not increase the risk of open-angle glaucoma or ocular hypertension--a 5-year follow-up. Graefes Arch Clin Exp Ophthalmol (2010) 1.57
Health literacy and adherence to glaucoma therapy. Am J Ophthalmol (2006) 1.57
Long-term functional outcome of macular hole surgery correlated to optical coherence tomography measurements. Clin Experiment Ophthalmol (2007) 1.56
Correlation of visual acuity and macular thickness measured by optical coherence tomography in patients with persistent macular edema. Retina (2010) 1.56
Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26. Arch Ophthalmol (2009) 1.53
Eye care in the United States: do we deliver to high-risk people who can benefit most from it? Arch Ophthalmol (2007) 1.53
Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema. Ophthalmology (2011) 1.52
Complex microcirculation patterns detected by confocal indocyanine green angiography predict time to growth of small choroidal melanocytic tumors: MuSIC Report II. Ophthalmology (2002) 1.52
Prospective study of risk factors for conjunctival bacterial contamination in patients undergoing intraocular surgery. Eur J Ophthalmol (2009) 1.52
Prevalence of posterior subcapsular cataracts in volunteer cytapheresis donors. Transfusion (2010) 1.51
Retinal damage from indocyanine green in experimental macular surgery. Invest Ophthalmol Vis Sci (2003) 1.50
Safety and long-term humoral immune response in adults after vaccination with an H1N1 2009 pandemic influenza vaccine with or without AS03 adjuvant. J Infect Dis (2012) 1.50
Intravitreal bevacizumab (Avastin) treatment is safe in terms of intraocular and blood pressure. Acta Ophthalmol Scand (2007) 1.49
One-year outcomes after retinal detachment surgery among medicare beneficiaries. Am J Ophthalmol (2010) 1.48
Real-time intraocular pressure measurement in standard and microcoaxial phacoemulsification. J Cataract Refract Surg (2010) 1.48
An electronic medical records system for clinical research and the EMR EDC interface. Invest Ophthalmol Vis Sci (2007) 1.48
Criterion for amino acid composition of defensins and antimicrobial peptides based on geometry of membrane destabilization. J Am Chem Soc (2011) 1.48
Evaluation of the relationship between ablation diameter, pupil size, and visual function with vision-specific quality-of-life measures after laser in situ keratomileusis. Arch Ophthalmol (2007) 1.47
Associations among cataract prevalence, sunlight hours, and altitude in the Himalayas. Am J Epidemiol (1983) 1.47
Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retina. Retina (2007) 1.46
An assessment of the health and economic burdens of glaucoma. Am J Ophthalmol (2011) 1.46
Ten-year incidence of age-related macular degeneration according to diabetic retinopathy classification among medicare beneficiaries. Retina (2013) 1.46
Long-term follow-up after macular hole surgery with internal limiting membrane peeling. Am J Ophthalmol (2002) 1.45
Nonmydriatic screening for diabetic retinopathy by ultra-widefield scanning laser ophthalmoscopy (Optomap). Graefes Arch Clin Exp Ophthalmol (2007) 1.45
Resident physician mentoring program in ophthalmology: the Tennessee experience. Arch Ophthalmol (2006) 1.44
Indocyanine green for successful repair of a long-standing macular hole. Am J Ophthalmol (2003) 1.42
Alternative vaccination schedule preferences among parents of young children. Pediatrics (2011) 1.41
Posterior vitreous detachment induced by microplasmin. Invest Ophthalmol Vis Sci (2004) 1.41
Estimates of incidence rates with longitudinal claims data. Arch Ophthalmol (2003) 1.37
Multi-MHz retinal OCT. Biomed Opt Express (2013) 1.36
Blindness prevention programmes: past, present, and future. Bull World Health Organ (2003) 1.35
Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes: early treatment diabetic retinopathy study report no. 27. Diabetes Care (2005) 1.34
Functional outcome of macular hole surgery with and without indocyanine green-assisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol (2003) 1.33
Identification of patients with diabetic macular edema from claims data: a validation study. Arch Ophthalmol (2008) 1.33
Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: Age-Related Eye Disease Study Report No. 28. Ophthalmology (2010) 1.32
Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4. JAMA Ophthalmol (2013) 1.31
Relationship between photoreceptor outer segment length and visual acuity in diabetic macular edema. Retina (2010) 1.30
The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study. Ophthalmology (2003) 1.30
Retinal pigment epithelium is protected against apoptosis by alphaB-crystallin. Invest Ophthalmol Vis Sci (2002) 1.30
Vision-related quality of life in people with central retinal vein occlusion using the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol (2003) 1.29
Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial. Retina (2007) 1.28
Hypomethylation of the IL17RC promoter associates with age-related macular degeneration. Cell Rep (2012) 1.28
Patterns of care for open-angle glaucoma in managed care. Arch Ophthalmol (2003) 1.28